UBS Initiates Prothena With Buy Rating, $58 Price Target
June 01, 2015 at 09:15 AM EDT
In a report published Monday, UBS analyst Andrew Peters initiated coverage of Prothena Corporation Plc (NASDAQ: PRTA) with a Buy rating ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.